Allt fler dör av metadon

Lakartidningen

Volumn 107, Issue 18, 2010, Pages 1225-1228

  Fugelstad, Anna ^a,b   Johansson, Lars Age ^c,d   Thiblin, Ingemar ^c,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Beroendecentrum   (Sweden)

^c Socialstyrelsen ^*  (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; STREET DRUG;

ARTICLE; BLOOD; CAUSE OF DEATH; FORENSIC TOXICOLOGY; HEROIN DEPENDENCE; HUMAN; INTOXICATION; MORTALITY; PRESCRIPTION; STATISTICS; SWEDEN;

ANALGESICS, OPIOID; CAUSE OF DEATH; DRUG PRESCRIPTIONS; FORENSIC TOXICOLOGY; HEROIN DEPENDENCE; HUMANS; METHADONE; NARCOTICS; OVERDOSE; POISONING; STREET DRUGS; SWEDEN;

EID: 77951946026     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Folkhälsoinstitutet. Dödsfall med förekomst av droger baserade på rättsmedicinska data. http://www.fhi.se/Documents/Statistik-uppfoljning/rattsmedicin/Rattsmed-tox-reg-09.pdf
2. Gunne LM, Grönbladh L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend. 1981;7(3):249-56.
3. Gerstein DR, Lewin LS. Treating drug problems. N Engl J Med. 1990;323(12):844-8.
4. Bertschy G. Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci. 1995;245(2):114-24.
5. Grönbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82(3): 223-7.
6. Fugelstad A, Rajs J, Böttiger M, Gerhardsson de Verdier M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction. 1995;90(5):711-6.
7. Fugelstad A, Agren G, Romelsjö A. Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment. Subst Use Misuse. 1998;33(14):2803-17.
8. Sorensen JL. Methadone treatment for opiate addicts. BMJ. 1996; 313(7052):245-6.
9. Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007;102(3):406-12.
10. Benbow EW, Roberts IS, Cairns A. Fatal methadone overdose. BMJ. 1997;314(7085):975.
11. Cairns A, Roberts IS, Benbow EW. Characteristics of fatal methadone overdose in Manchester, 1985-94. BMJ. 1996;313(7052):264-5.
12. La Harpe R, Fryc O. [Fatalities associated with methadone administration in the Geneva canton (1987-1993)]. Arch Kriminol. 1995; 196(1-2):24-9.
13. Heinemann A, Iwersen-Bergmann S, Stein S, Schmoldt A, Puschel K. Methadone-related fatalities in Hamburg 1990-1999: implications for quality standards in maintenance treatment? Forensic Sci Int. 2000;113(1-3):449-55.
14. Corkery JM, Schifano F, Ghodse AH, Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol. 2004;19(8):565-76.
15. Kornor H, Waal H. Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation. Tidsskr Nor Laegeforen. 2004;124(3):332-4.
16. Shields LB, Hunsaker III JC, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci. 2007;52(6):1389-95.
17. Hearing om missbruk av Subutex (buprenorfin). 2008. http://www.lakemedelsverket.se/Alla-nyheter/NYHETER-2008/Hearing-om-Subutexmissbruk
18. Fugelstad A, Ahlner J, Brandt L, Ceder G, Eksborg S, Rajs J, et al. Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction. 2003;98(4):463-70.
19. Pedersen CL, Steentoft A, Kringsholm B. [Deaths among drug addicts in Eastern Denmark 2005]. Ugeskr Laeger. 2008;170(50):4124-7.
20. Vouri E. Buprenorphin, an abused opioid. European cities against drugs, mayors conference; 2006. 02.06.2006; Vilnius. 2006.